Alitretinoin

What is Alitretinoin?

Alitretinoin is a synthetic retinoid, a class of compounds chemically related to vitamin A. It is primarily used in dermatology for the treatment of **severe chronic hand eczema** (CHE) that has not responded to potent topical corticosteroids. Available as an oral capsule, Alitretinoin works systemically to address the underlying inflammatory processes contributing to this debilitating skin condition. In some regions, it is marketed under the brand name **Toctino**.

Chronic hand eczema, characterized by dryness, redness, scaling, blistering, and intense itching, significantly impairs quality of life. When topical treatments fail, systemic options like Alitretinoin become crucial.

How Does it Work?

The mechanism of action of Alitretinoin involves its interaction with specific nuclear **retinoid receptors** within cells. As an endogenous retinoid, it binds to both retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which are key regulators of gene expression. By activating these receptors, Alitretinoin modulates various cellular processes, including cell growth, differentiation, and apoptosis.

In eczema, Alitretinoin exerts anti-inflammatory and immunomodulatory effects. It helps to normalize abnormal keratinocyte differentiation and proliferation and reduces the activity of immune cells involved in the inflammatory cascade. This comprehensive action helps restore skin barrier function and reduce the severity of chronic hand eczema.

Medical Uses

The primary medical use for Alitretinoin is the treatment of adults with **severe chronic hand eczema** that is refractory to potent topical corticosteroids. This means patients must have tried and failed to respond adequately to strong steroid creams or ointments.

Chronic hand eczema is defined as hand eczema lasting over three months or recurring within 12 months. Alitretinoin offers a valuable therapeutic option for individuals suffering despite conventional treatments, providing significant improvement. It is a prescription-only medication, requiring initiation and monitoring by a physician experienced in treating severe dermatological conditions.

Dosage

Alitretinoin is administered orally as soft capsules. The typical starting dose for adults is either 10 mg or 30 mg once daily, taken with a main meal to enhance absorption. Treatment usually continues for 12 to 24 weeks, or until the hand eczema is clear or almost clear. If symptoms recur, a second course may be considered. Due to potential side effects and the need for careful monitoring, Alitretinoin treatment requires regular follow-up appointments.

Side Effects

Common side effects often resemble those associated with other retinoids and include headache, dry skin, dry lips, dry eyes, and nosebleeds. These are generally dose-dependent and manageable with supportive care.

More serious concerns include potential elevations in blood lipid levels and liver enzyme abnormalities, necessitating regular blood tests. Alitretinoin is also highly **teratogenic**, meaning it can cause severe birth defects. It is absolutely contraindicated in pregnant women, and women of childbearing potential must use effective contraception for one month before, during, and for one month after treatment. A negative pregnancy test must be confirmed before starting and monthly thereafter.

Other potential side effects include photosensitivity and musculoskeletal pain. Patients should report any unusual or severe symptoms to their doctor immediately.

Drug Interactions

Several drug interactions can occur with Alitretinoin. Inform your doctor about all medications, supplements, and herbal products you are taking. Key interactions include:

• Other Retinoids: Avoid concomitant use due to risk of additive toxicity (hypervitaminosis A-like symptoms).
• Tetracyclines: Increases risk of pseudotumor cerebri (benign intracranial hypertension).
• Vitamin A Supplements: Avoid to prevent exacerbating retinoid-related side effects.
• CYP3A4 Inducers/Inhibitors: Drugs like rifampicin, ketoconazole, or phenytoin can alter Alitretinoin levels, requiring monitoring or dose adjustments.

Always consult your healthcare professional for a complete list of potential interactions.

FAQ

Is Alitretinoin a cure for hand eczema?

While Alitretinoin can lead to significant improvement and even clearance of severe chronic hand eczema, it is not considered a permanent cure. Relapse may occur, potentially requiring a second course.

How long does it take to see results?

Improvements typically begin within 4 to 8 weeks. Full benefits often become apparent towards the end of the 12- to 24-week treatment course.

What if I miss a dose?

If you miss a dose, take it with a main meal as soon as you remember. If it's almost time for your next dose, skip the missed one and continue your regular schedule. Do not take a double dose.

Can I use topical treatments with Alitretinoin?

Yes, emollients or mild topical corticosteroids may be recommended by your doctor in conjunction with Alitretinoin to manage dryness and inflammation.

Is Alitretinoin safe during pregnancy?

Absolutely NOT. It is highly teratogenic and strictly contraindicated during pregnancy due to severe risk of birth defects. Women of childbearing potential must adhere to a strict pregnancy prevention program.

Products containing Alitretinoin are available through trusted online pharmacies. You can browse Alitretinoin-based medications at ShipperVIP or Medicenter.

Summary

Alitretinoin is an important **oral retinoid** medication specifically approved for the treatment of **chronic hand dermatitis** that is severe and has not responded to conventional topical therapies. By modulating gene expression through retinoid receptors, it helps to reduce inflammation and normalize skin cell processes. While effective, it requires careful medical supervision due to potential side effects, including **teratogenicity**, and necessitates strict adherence to dosage and monitoring guidelines. For patients struggling with persistent and debilitating hand eczema, Alitretinoin offers a valuable systemic option to improve their condition and quality of life.